Jw Life Science Corp (KO:234080) — Market Cap & Net Worth
Market Cap & Net Worth: Jw Life Science Corp (234080)
Jw Life Science Corp (KO:234080) has a market capitalization of $135.68 Million (₩200.22 Billion) as of May 2, 2026. Listed on the KO stock exchange, this Korea-based company holds position #18022 globally and #884 in its home market, demonstrating a 1.17% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jw Life Science Corp's stock price ₩12930.00 by its total outstanding shares 15484554 (15.48 Million). Analyse cash flow conversion of Jw Life Science Corp to see how efficiently the company converts income to cash.
Jw Life Science Corp Market Cap History: 2016 to 2026
Jw Life Science Corp's market capitalization history from 2016 to 2026. Data shows change from $120.56 Million to $135.68 Million (-3.21% CAGR).
Jw Life Science Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jw Life Science Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Jw Life Science Corp's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Jw Life Science Corp's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $120.56 Million | $132.29 Billion | $15.16 Billion | 0.00x | 0.01x |
| 2017 | $190.17 Million | $143.60 Billion | $16.78 Billion | 0.00x | 0.01x |
| 2018 | $203.13 Million | $155.23 Billion | $15.82 Billion | 0.00x | 0.01x |
| 2019 | $187.94 Million | $170.22 Billion | $21.94 Billion | 0.00x | 0.01x |
| 2020 | $201.89 Million | $183.52 Billion | $16.87 Billion | 0.00x | 0.01x |
| 2021 | $139.64 Million | $169.82 Billion | $12.91 Billion | 0.00x | 0.01x |
| 2022 | $127.50 Million | $188.93 Billion | $14.96 Billion | 0.00x | 0.01x |
| 2023 | $135.05 Million | $206.86 Billion | $28.14 Billion | 0.00x | 0.00x |
| 2024 | $114.17 Million | $222.48 Billion | $43.99 Billion | 0.00x | 0.00x |
Competitor Companies of 234080 by Market Capitalization
Companies near Jw Life Science Corp in the global market cap rankings as of May 2, 2026.
Key companies related to Jw Life Science Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Jw Life Science Corp Historical Marketcap From 2016 to 2026
Between 2016 and today, Jw Life Science Corp's market cap moved from $120.56 Million to $ 135.68 Million, with a yearly change of -3.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩135.68 Million | +0.62% |
| 2025 | ₩134.84 Million | +18.11% |
| 2024 | ₩114.17 Million | -15.46% |
| 2023 | ₩135.05 Million | +5.93% |
| 2022 | ₩127.50 Million | -8.69% |
| 2021 | ₩139.64 Million | -30.83% |
| 2020 | ₩201.89 Million | +7.42% |
| 2019 | ₩187.94 Million | -7.48% |
| 2018 | ₩203.13 Million | +6.82% |
| 2017 | ₩190.17 Million | +57.73% |
| 2016 | ₩120.56 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Jw Life Science Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $135.68 Million USD |
| MoneyControl | $135.68 Million USD |
| MarketWatch | $135.68 Million USD |
| marketcap.company | $135.68 Million USD |
| Reuters | $135.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jw Life Science Corp
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed … Read more